.png)
Supercharging Patient Activation
Financial Services
Case Background
A global healthcare company headquartered in Europe had successfully launched a rare disease drug in the US using best-in-class approaches. After a year on the market, the leadership team recognized the need for innovative solutions to further grow the business. Despite the initial success, they saw untapped potential and sought strategies to expand their reach and impact. To address this, we were engaged to help our Client solve a critical question: “How can we activate more patients for Product X in a way that creates value for patients, providers, and the company?” This challenge required a strategic approach that balanced patient engagement, provider support, and business growth, aiming to enhance overall outcomes and market penetration.
We applied our proven strategic innovation approach, FRAME, CREATE, PRIME, to develop new patient activation solutions for Product X, aiming to go beyond industry best practices. During the FRAME phase, we identified and prioritized challenges through a comprehensive process involving stakeholder interviews, a tactics deep dive, field force surveys, and our internal assessment. Five core challenges were agreed upon during the FRAME workshop and pressure-tested to pinpoint the three patient activation challenges that would drive the greatest ROI. These insights guided our efforts in the CREATE phase, where we meticulously filtered through hundreds of precedents for best practices both within and outside of the pharmaceutical industry, focusing on those that faced similar challenges to Product X. From this extensive research, four winning themes emerged from the most successful orphan drug strategies: shaping transitions of care, increasing the power of the patient story, offering best-in-class concierge services, and creating awareness through empathy. These themes provided a robust foundation for developing innovative and effective patient activation strategies tailored to the unique needs of Product X. In the final phase, PRIME, our team collaborated closely with the client to operationalize these strategic recommendations.
Our Approach
Key learnings from the most successful orphan drugs and winning precedent insights informed 13 strategic recommendations designed to revolutionize existing strategies, enhance tactics, optimize salesforce training and readiness, and introduce groundbreaking ideas to activate new patients. We utilized advanced implementation tools and frameworks, ensuring each recommendation was seamlessly integrated into the company’s operations. This comprehensive approach not only empowered the client with actionable plans but also positioned them to achieve significant market growth and patient engagement, driving the success of Product X.
Output
Supercharging Patient Activation
Financial Services
Case Background
A global healthcare company headquartered in Europe had successfully launched a rare disease drug in the US using best-in-class approaches. After a year on the market, the leadership team recognized the need for innovative solutions to further grow the business. Despite the initial success, they saw untapped potential and sought strategies to expand their reach and impact. To address this, we were engaged to help our Client solve a critical question: “How can we activate more patients for Product X in a way that creates value for patients, providers, and the company?” This challenge required a strategic approach that balanced patient engagement, provider support, and business growth, aiming to enhance overall outcomes and market penetration.
We applied our proven strategic innovation approach, FRAME, CREATE, PRIME, to develop new patient activation solutions for Product X, aiming to go beyond industry best practices. During the FRAME phase, we identified and prioritized challenges through a comprehensive process involving stakeholder interviews, a tactics deep dive, field force surveys, and our internal assessment. Five core challenges were agreed upon during the FRAME workshop and pressure-tested to pinpoint the three patient activation challenges that would drive the greatest ROI. These insights guided our efforts in the CREATE phase, where we meticulously filtered through hundreds of precedents for best practices both within and outside of the pharmaceutical industry, focusing on those that faced similar challenges to Product X. From this extensive research, four winning themes emerged from the most successful orphan drug strategies: shaping transitions of care, increasing the power of the patient story, offering best-in-class concierge services, and creating awareness through empathy. These themes provided a robust foundation for developing innovative and effective patient activation strategies tailored to the unique needs of Product X. In the final phase, PRIME, our team collaborated closely with the client to operationalize these strategic recommendations.
Our Approach
Key learnings from the most successful orphan drugs and winning precedent insights informed 13 strategic recommendations designed to revolutionize existing strategies, enhance tactics, optimize salesforce training and readiness, and introduce groundbreaking ideas to activate new patients. We utilized advanced implementation tools and frameworks, ensuring each recommendation was seamlessly integrated into the company’s operations. This comprehensive approach not only empowered the client with actionable plans but also positioned them to achieve significant market growth and patient engagement, driving the success of Product X.